Perioperative coronary stent thrombosis is a catastrophic complication that can occur in patients receiving both bare-metal and drug-eluting stents. Noncardiac surgery appears to increase the risk that recently-placed stents thrombose, especially when surgery is performed early after stenting, and particularly if dual antiplatelet therapy is discontinued. We reviewed the existing data about the frequency of stent thrombosis after noncardiac surgery and explored the impact of delay from surgery and discontinuation of antiplatelet therapy. We also reviewed the data about the impact of preoperative revascularization in patients known to require noncardiac surgery. Based on these published data, we offer recommendations that can be used to guid...
The perioperative management of antiplatelet therapy in noncardiac surgery patients who have undergo...
The aim was to investigate the perioperative risk of ischaemic and bleeding events in patients with ...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...
Perioperative coronary stent thrombosis is a catastrophic complication that can occur in patients re...
AbstractOBJECTIVESTo assess the clinical course of patients who have undergone coronary stent placem...
Background: It is unclear how to appropriately manage discontinuation and resumption of antiplatelet...
Background. Recent publications have reported high incidence of perioperative complications in patie...
OBJECTIVES To assess the clinical course of patients who have undergone coronary stent placement les...
About 5% of patients undergoing coronary stenting need to undergo surgery within the next year. The ...
BACKGROUND:The correct perioperative management of antiplatelet therapy (APT) in patients undergoing...
Abstract Background The correct perioperative management of antiplatelet therapy (APT) in patients u...
With widespread use of Drug Eluting Stents (DES), perioperative dual antiplatelet issues are becomin...
For evaluation of post-operative stent associated cardiac events after drug-eluting stent (DES) impl...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...
Background. A 45 % complication rate and a mortality of 20 % were reported previously in patients un...
The perioperative management of antiplatelet therapy in noncardiac surgery patients who have undergo...
The aim was to investigate the perioperative risk of ischaemic and bleeding events in patients with ...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...
Perioperative coronary stent thrombosis is a catastrophic complication that can occur in patients re...
AbstractOBJECTIVESTo assess the clinical course of patients who have undergone coronary stent placem...
Background: It is unclear how to appropriately manage discontinuation and resumption of antiplatelet...
Background. Recent publications have reported high incidence of perioperative complications in patie...
OBJECTIVES To assess the clinical course of patients who have undergone coronary stent placement les...
About 5% of patients undergoing coronary stenting need to undergo surgery within the next year. The ...
BACKGROUND:The correct perioperative management of antiplatelet therapy (APT) in patients undergoing...
Abstract Background The correct perioperative management of antiplatelet therapy (APT) in patients u...
With widespread use of Drug Eluting Stents (DES), perioperative dual antiplatelet issues are becomin...
For evaluation of post-operative stent associated cardiac events after drug-eluting stent (DES) impl...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...
Background. A 45 % complication rate and a mortality of 20 % were reported previously in patients un...
The perioperative management of antiplatelet therapy in noncardiac surgery patients who have undergo...
The aim was to investigate the perioperative risk of ischaemic and bleeding events in patients with ...
Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoi...